Lubiprostone
FDA Approved: * November 30, 2021Pharm Company: * AMNEAL PHARMS NY
Category: Irritable Bowel Syndrome
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company. The drug was developed by Sucampo Pharmaceuticals and approved by the Food and Drug Administration (FDA) in 2006.[1][2][3... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Lubiprostone 24 ug/1 Oral Capsule, Gelatin Coated
NDC: 0480-4138
Labeler:
Teva Pharmaceuticals, Inc.
Lubiprostone 8 ug/1 Oral Capsule, Gelatin Coated
NDC: 43598-163
Labeler:
Dr. Reddy's Laboratories Inc.
Lubiprostone 24 ug/1 Oral Capsule, Gelatin Coated
NDC: 43598-168
Labeler:
Dr. Reddy's Laboratories Inc.